Category

Deliver Proven Solutions Faster – Implementation Science

Gillings researchers fight emerging diseases

July 5, 2018 Utilizing the expertise of the Baric Lab at the UNC Gillings School, Gilead Sciences is making breakthroughs in developing drugs to fight some of the world’s deadliest viruses. The Gilead broad-spectrum treatment that was tested and proven in the Baric Lab, now known as Remdesivir, was deployed for use in the Ebola outbreak in the Democratic Republic of the Congo.